Phenox

Focus: Phenox is a German medical device company specializing in implantable neurovascular devices, guidewires, and thrombectomy systems for stroke and aneurysm treatment. The company operates in the high-stakes neurointerventional space with a focused product portfolio targeting acute neurological emergencies.

Neurology

Profile data last refreshed Yesterday · AI intelligence enriched 1w ago

Open Jobs

About Phenox

AI assessmentNot Hiring

No open roles listed right now. Follow Phenox to get notified when they start hiring — the background below is worth knowing for when they do.

Why Work Here

Data completeness

1/9 — Limited

Company HealthSolid

Pipeline

Early-stage

15 total

LOE Risk

Protected

No near-term cliffs

Hiring

0 open

Automated analysis based on publicly available data (FDA, SEC, ClinicalTrials.gov). May be incomplete or delayed. This score does not reflect insider knowledge and should not be used as the sole basis for investment or employment decisions.

Pipeline & Clinical Trials

Endovascular Therapy

Acute Ischemic Stroke

N/A

Stent retriever endovascular device for thrombectomy

Ischemic Stroke

N/A

Flow diversion

Help build intelligence for Phenox

No one has shared interview or compensation data for this company yet. You'll earn 7 days of Pro access.

Share Interview Share Compensation

Data Sources

Drug label: DailyMed / FDA
Clinical trials: ClinicalTrials.gov
Patent data: FDA Orange Book
Spending data: CMS Medicare

The information on this page is for informational purposes only and should not be used as a substitute for professional medical advice. Drug information is sourced from FDA, DailyMed, and other government databases. Adverse event data from FAERS does not establish causation. Always consult a healthcare professional for medical decisions.

Deep focus on neurovascular disease with 15 pipeline programs across stroke and aneurysm indications, offering specialized career development in a high-impact therapeutic area
Established device portfolio with active clinical programs and post-market studies, providing exposure to real-world evidence generation and commercial-stage device optimization
German-based headquarters provides access to European regulatory expertise and a strong medical device ecosystem with established manufacturing and quality systems

Watch Out For

Zero active job openings at time of analysis—hiring appears dormant or consolidated, limiting immediate employment opportunities
Limited public visibility on financials, funding, revenue, and employee count creates uncertainty around company stability and growth trajectory for prospective candidates

Generated by Claude from Phenox's SEC filings, pipeline programs, hiring velocity, FDA actions, and WARN data. Inference, not editorial — verify before quoting.

Clinical Trials (1)

NCT07143019The Use of p48/64 MW HPC Flow Modulation Device in the Treatment of Wide-necked Intracranial Aneurysms

N/A

Intracranial stenting

Stroke

N/A

pREset thrombectomy retriever

Stroke

N/A

Clinical Trials (1)

NCT02437409Acute Recanalization of Thrombo-Embolic Ischemic Stroke With pREset (ARTESp)

N/A